3. Methodenforum der Cochrane Deutschland Stiftung:
Opportunities, Limitations and Risks of Artificial Intelligence in Evidence Synthesis in Health Care
When: 14th June 2024 (9.30 am to 5.30 pm, get together: 5.30 pm to 7.30 pm)
Where: Haus zur Lieben Hand (Löwenstraße 16, 79098 Freiburg, Germany)
Participation fees: 85 € (for students with certificate of enrolment: 50 €)
The 3rd Methods-Forum in 2024 is dedicated to a highly relevant topic that is playing an increasingly important role in the field of evidence synthesis: Opportunities, Limitations, and Risks of Artificial Intelligence in Evidence Synthesis in Health Care.
The continuous advancements in AI, automation, and language processing have a growing impact on how evidence syntheses could be created and utilised. The development of AI language models (e.g., ChatGPT, Claude) and the evolution of automation tools (e.g., ASReview, Laser AI, DistillerSR) present new opportunities and challenges in areas such as search strategy development, screening and data extraction, as well as in risk of bias assessment. This creates opportunities for faster conducting or updating of evidence syntheses, which can be of great significance for evidence synthesis creators and users. In the framework of the 2024 Methods-Forum, we will illuminate the various steps in evidence synthesis and the role of AI language models in these steps.
However, the use of AI for evidence synthesis requires a comprehensive understanding of its strengths and weaknesses. To create high-quality evidence syntheses with the support of AI, it is crucial to be aware of the limitations of AI language models and automation tools. At the 2024 Methods-Forum, we aim to reflect on whether and how they can be combined with traditional methods of evidence synthesis.
The 2024 Methods-Forum is an excellent opportunity to discuss activities related to evidence syntheses with experts in the field of AI language models and automation tools and to weigh opportunities, limitations, and risks. The event is designed for those with basic knowledge in the methodology of systematic reviews who wish to stay informed about current developments in the field of AI and evidence synthesis or contribute their own experiences.
For this event medical doctors can claim 8 points at LÄK Baden-Württemberg.
We are very excited to announce the following speakers who will be sharing their expertise with us:
Harald Binder, Institute of Medical Biometry and Statistics (IMBI), Faculty of Medicine and Medical Centre, University of Freiburg, Germany
Angelika Eisele-Metzger, Institute for Evidence in Medicine, Faculty of Medicine and Medical Centre, University of Freiburg, Germany; Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany
Maria-Inti Metzendorf, Institute of General Practice (ifam), Medical Faculty of the Heinrich-Heine-University Düsseldorf, Germany
Siw Waffenschmidt, Institute for Quality and Efficiency in Health Care, Cologne, Germany
Gerald Gartlehner, Department for Evidence-based Medicine and Evaluation, Cochrane Austria, University of Krems, Austria
Daniel Böhringer, Eye Centre, University Hospital Freiburg, Medical Faculty, University of Freiburg, Germany
Riaz Qureshi, Cochrane Eyes and Vision, Departments of Ophthalmology and Epidemiology, University of Colorado Anschutz Medical Campus, USA
Artur Nowak, Evidence Prime, Kraków, Poland
Piet Hanegraaf, Founder and CEO at Pitts.ai
Jacob-Jan Mosselman, Pitts.ai
James Thomas, EPPI Centre, Social Research Institute, University College London, UK